Item request has been placed!
×
Item request cannot be made.
×
Processing Request
The Same Metabolic Response to FGF21 Administration in Male and Female Obese Mice Is Accompanied by Sex-Specific Changes in Adipose Tissue Gene Expression.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
- بيانات النشر:
Original Publication: Basel, Switzerland : MDPI, [2000-
- الموضوع:
- نبذة مختصرة :
The preference for high-calorie foods depends on sex and contributes to obesity development. Fibroblast growth factor 21 (FGF21) beneficially affects taste preferences and obesity, but its action has mainly been studied in males. The aim of this study was to compare the effects of FGF21 on food preferences and glucose and lipid metabolism in C57Bl/6J male and female mice with diet-induced obesity. Mice were injected with FGF21 or vehicle for 7 days. Body weight, choice between standard (SD) and high-fat (HFD) diets, blood parameters, and gene expression in white (WAT) and brown (BAT) adipose tissues, liver, muscles, and the hypothalamus were assessed. Compared to males, females had a greater preference for HFD; less WAT; lower levels of cholesterol, glucose, and insulin; and higher expression of Fgf21 , Insr , Ppara , Pgc1 , Acca and Accb in the liver and Dio2 in BAT. FGF21 administration decreased adiposity; blood levels of cholesterol, glucose, and insulin; hypothalamic Agrp expression, increased SD intake, decreased HFD intake independently of sex, and increased WAT expression of Pparg, Lpl and Lipe only in females. Thus, FGF21 administration beneficially affected mice of both sexes despite obesity-associated sex differences in metabolic characteristics, and it induced female-specific activation of gene expression in WAT.
- References:
Int J Mol Sci. 2019 Sep 21;20(19):. (PMID: 31546675)
J Physiol. 2019 Aug;597(15):3885-3903. (PMID: 31206703)
Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1105-14. (PMID: 19706786)
Exp Physiol. 2018 Mar 1;103(3):408-418. (PMID: 29215172)
Endocrinology. 2008 Dec;149(12):6018-27. (PMID: 18687777)
Cell Metab. 2014 Oct 7;20(4):670-7. (PMID: 25130400)
Endocrinol Metab (Seoul). 2021 Apr;36(2):209-219. (PMID: 33866777)
Am J Clin Nutr. 2013 Jun;97(6):1395-402. (PMID: 23636237)
Hum Mol Genet. 2013 May 1;22(9):1895-902. (PMID: 23372041)
Int J Obes (Lond). 2012 Feb;36(2):262-72. (PMID: 21540832)
Int J Mol Sci. 2018 Nov 02;19(11):. (PMID: 30400212)
Cell Metab. 2016 Oct 11;24(4):555-565. (PMID: 27693377)
Autophagy. 2019 Jan;15(1):131-150. (PMID: 30209975)
Cell Metab. 2020 Aug 4;32(2):273-286.e6. (PMID: 32640184)
Endocrinology. 2019 May 1;160(5):1069-1080. (PMID: 30802283)
Cell Metab. 2016 Feb 9;23(2):335-43. (PMID: 26724858)
Endocrinology. 2013 Sep;154(9):3366-76. (PMID: 23825123)
Cell Metab. 2018 Sep 4;28(3):415-431.e4. (PMID: 30017356)
Endocrinology. 2012 Sep;153(9):4192-203. (PMID: 22798348)
Nutr Diabetes. 2017 Apr 10;7(4):e261. (PMID: 28394359)
Front Physiol. 2018 Oct 23;9:1452. (PMID: 30405427)
Am J Physiol Endocrinol Metab. 2017 Aug 1;313(2):E203-E212. (PMID: 28559436)
Am J Physiol Endocrinol Metab. 2021 Aug 1;321(2):E292-E304. (PMID: 34229476)
Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R814-21. (PMID: 11171662)
Eur J Biochem. 1999 Mar;260(2):505-11. (PMID: 10095788)
Cell Metab. 2017 Jun 6;25(6):1216-1230. (PMID: 28591630)
Trends Endocrinol Metab. 2011 Mar;22(3):81-6. (PMID: 21194964)
Endocrinology. 2006 Feb;147(2):875-84. (PMID: 16269451)
J Physiol. 2019 Jul;597(14):3539-3548. (PMID: 30921473)
Vavilovskii Zhurnal Genet Selektsii. 2020 Mar;24(2):200-208. (PMID: 33659800)
Cell Rep. 2019 Jun 4;27(10):2934-2947.e3. (PMID: 31167139)
Diabetes. 2014 Dec;63(12):4057-63. (PMID: 25008183)
Eur J Nutr. 2012 Oct;51(7):861-70. (PMID: 22042005)
Nat Rev Endocrinol. 2020 Nov;16(11):654-667. (PMID: 32764725)
Nat Metab. 2021 Mar;3(3):309-317. (PMID: 33758421)
Neurobiol Stress. 2021 Jun 28;15:100360. (PMID: 34277896)
Cells. 2019 Nov 27;8(12):. (PMID: 31783664)
Cell Metab. 2016 Mar 8;23(3):441-53. (PMID: 26853749)
Trends Endocrinol Metab. 2021 Feb;32(2):95-105. (PMID: 33384209)
Prog Lipid Res. 2014 Jan;53:124-44. (PMID: 24362249)
Elife. 2012 Oct 15;1:e00065. (PMID: 23066506)
Physiol Behav. 2018 Apr 1;187:2-5. (PMID: 28823546)
Diabetes. 2009 Jan;58(1):250-9. (PMID: 18840786)
J Endocrinol. 2019 Apr 1;241(1):R1-R33. (PMID: 30812013)
Front Endocrinol (Lausanne). 2021 Apr 13;12:652444. (PMID: 33927694)
Cell Metab. 2016 Feb 9;23(2):344-9. (PMID: 26724861)
J Clin Invest. 2005 Jun;115(6):1627-35. (PMID: 15902306)
Cell Metab. 2017 May 2;25(5):1045-1053.e6. (PMID: 28467924)
Proc Natl Acad Sci U S A. 2020 Nov 17;117(46):28992-29000. (PMID: 33139537)
Mol Metab. 2013 Dec 27;3(3):221-9. (PMID: 24749049)
Lancet. 2011 Aug 27;378(9793):804-14. (PMID: 21872749)
Sci Rep. 2020 Nov 11;10(1):19521. (PMID: 33177640)
Oncotarget. 2016 Jul 26;7(30):46959-46971. (PMID: 27409675)
Cell Metab. 2017 Apr 4;25(4):935-944.e4. (PMID: 28380381)
Biochim Biophys Acta Mol Basis Dis. 2018 Jul;1864(7):2495-2509. (PMID: 29653185)
J Hepatol. 2015 Mar;62(3):720-33. (PMID: 25450203)
Mol Metab. 2019 Apr;22:62-70. (PMID: 30797705)
Mol Metab. 2021 Apr;46:101152. (PMID: 33383173)
Cell Metab. 2016 May 10;23(5):770-84. (PMID: 27166942)
Int J Obes (Lond). 2021 Aug;45(8):1773-1781. (PMID: 34002038)
- Grant Information:
17-15-01036 Russian Science Foundation
- Contributed Indexing:
Keywords: FGF21; food preferences; gene expression; mice; obesity; sex differences
- الرقم المعرف:
0 (Blood Glucose)
0 (Insulin)
0 (PPAR alpha)
0 (Ppara protein, mouse)
0 (fibroblast growth factor 21)
62031-54-3 (Fibroblast Growth Factors)
97C5T2UQ7J (Cholesterol)
EC 2.3.1.85 (Fasn protein, mouse)
EC 2.3.1.85 (Fatty Acid Synthase, Type I)
EC 2.7.1.40 (Pyruvate Kinase)
- الموضوع:
Date Created: 20211013 Date Completed: 20211101 Latest Revision: 20240226
- الموضوع:
20240226
- الرقم المعرف:
PMC8508620
- الرقم المعرف:
10.3390/ijms221910561
- الرقم المعرف:
34638898
No Comments.